Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

SH, Hohnloser; J, Oldgren; S, Yang; L, Wallentin; M, Ezekowitz; P, Reilly; J, Eikelboom; M, Brueckmann; S, Yusuf; SJ, Connolly

doi:10.1161/circulationaha.111.055970

Public

Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.

Shared by NobleBlocks on Jan 3, 2012 • 12:00 AM UTC

Authors:

Hohnloser SH

Oldgren J

Yang S

Abstract

<h4>Background</h4>There is a modest risk of myocardial infarction (MI) and myocardial ischemic events in patients with atrial fibrillation.<h4>Methods and results</h4>Data from the RE-LY study (Randomized Evaluation of Long-Term Anticoagulation Therapy) were used to report rates of MI, unstable ang...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!